Biochemical characterisation of an α1,4 galactosyltransferase from Neisseria weaveri for the synthesis of α1,4-linked galactosides.


Journal

Organic & biomolecular chemistry
ISSN: 1477-0539
Titre abrégé: Org Biomol Chem
Pays: England
ID NLM: 101154995

Informations de publication

Date de publication:
29 04 2020
Historique:
pubmed: 8 4 2020
medline: 22 9 2020
entrez: 8 4 2020
Statut: ppublish

Résumé

The human cell surface trisaccharide motifs globotriose and P1 antigen play key roles in infections by pathogenic bacteria, which makes them important synthetic targets as antibacterial agents. Enzymatic strategies to install the terminal α1,4-galactosidic linkage are very attractive but have only been demonstrated for a limited set of analogues. Herein, a new bacterial α1,4 galactosyltransferase from N. weaveri was cloned and produced recombinantly in E. coli BL21 (DE3) cells, followed by investigation of its substrate specificity. We demonstrate that the enzyme can tolerate galactosamine (GalN) and also 6-deoxygalactose and 6-deoxy-6-fluorogalactose as donors, and lactose and N-acetyllactosamine as acceptors, leading directly to analogues of Gb3 and P1 that are valuable chemical probes and showcase how biocatalysis can provide fast access to a number of unnatural carbohydrate analogues.

Identifiants

pubmed: 32255449
doi: 10.1039/d0ob00407c
doi:

Substances chimiques

Amino Sugars 0
Bacterial Proteins 0
Galactosides 0
Globosides 0
Trisaccharides 0
galactopyranosyl-1-4-paragloboside 0
N-acetyllactosamine 3Y5B2K5OOK
globotriose 66580-68-5
Galactosamine 7535-00-4
Galactosyltransferases EC 2.4.1.-
UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferase EC 2.4.1.-
Lactose J2B2A4N98G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3142-3148

Auteurs

Kun Huang (K)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Andrea Marchesi (A)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Kristian Hollingsworth (K)

School of Chemistry and Asbury Centre for Structural Molecular Biology, The University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.

Peter Both (P)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Ashley P Mattey (AP)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Edward Pallister (E)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Helene Ledru (H)

School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.

Simon J Charnock (SJ)

Prozomix Ltd, Station Court, Haltwhistle, Northumberland, NE49 9HN, UK.

M Carmen Galan (MC)

School of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.

W Bruce Turnbull (WB)

School of Chemistry and Asbury Centre for Structural Molecular Biology, The University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.

Fabio Parmeggiani (F)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk and Department of Chemistry, Materials and Chemical Engineering "G. Natta", Politecnico di Milano, Via Mancinelli 7, 20131, Milano, Italy. fabio.parmeggiani@polimi.it.

Sabine L Flitsch (SL)

Manchester Institute of Biotechnology (MIB), School of Chemistry, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. sabine.flitsch@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH